Research shows that black men have a 25% chance of being diagnosed with prostate cancer.

The UK government has introduced new guidance restricting access to prostate-specific antigen (PSA) tests for men over 50, sparking outrage among health experts and patients. Under the revised policy, general practitioners will now decide whether to recommend PSA testing based on individual risk factors rather than age alone. Former Prime Minister Lord David Cameron condemned the move as a 'backwards step', arguing that early detection is critical for effective treatment. Prostate cancer remains the most common cancer in men, with over 63,000 diagnoses and 12,000 deaths annually. Critics claim the policy will delay diagnoses and increase mortality rates, particularly among high-risk groups. The decision follows the government's shift from widespread screening to targeted testing for at-risk individuals. Health campaigners highlight that focal therapy—a non-invasive treatment—could significantly improve outcomes but remains underutilized on the NHS. High-profile cases, including those of Jeremy Clarkson and Chris Hoy, have intensified calls for accessible PSA testing. Despite the controversy, officials insist patients retain the right to request tests, though final decisions rest with GPs.

An overwhelming 86 per cent of the public want a national screening programme put in place that could identify the disease earlier.